Refractory hypocalcaemia complicating metastatic prostatic carcinoma
نویسندگان
چکیده
منابع مشابه
Prostatic carcinoma metastatic to choroid.
Metastatic prostatic carcinoma of the choroid became clinically undetectable after orchidectomy and oestrogen administration. The choroidal tumour rapidly regressed over a 2-month period and clinically disappeared, with restoration of 6/6 vision from 6/60 and return of visual field. This dramatic response and lack of complications make hormonal manipulation the preferred mode of initial therapy...
متن کاملProstatic carcinoma metastatic to the optic nerve.
Optic nerve can be infiltrated with various tumors and inflammatory processes, with a considerable prevalence of primary over secondary tumors. Metastases of gastric carcinoma to the optic nerve are less frequently, and those of prostatic carcinoma very infrequently observed. A 66-year-old man presented with metastasis to the optic nerve with consequential vision loss to the level of light perc...
متن کاملMetastatic prostatic carcinoma to testis: histological features mimicking lymphoma.
We report a case of prostatic carcinoma with testicular metastasis, which mimicked malignant lymphoma of the testis. The patient was a 71 year-old man with a history of prostate adenocarcinoma of Gleason score 9 (4+5) diagnosed in 2001 for which he received hormonal therapy. Four years later, the patient developed multiple osteoblastic bone metastases. Radiotherapy of the bone metastases was gi...
متن کاملTemsirolimus in VEGF-refractory metastatic renal cell carcinoma.
BACKGROUND Temsirolimus is an i.v. administered inhibitor of mammalian target of rapamycin with activity in the first-line setting in poor-prognosis patients with metastatic renal cell carcinoma (RCC). The efficacy of this agent after failure of prior inhibitors of vascular endothelial growth factor (VEGF) is unknown. METHODS a retrospective review of patients with metastatic RCC treated at t...
متن کاملUnexpected prolonged extreme hypocalcaemia and an inadequate PTH response in a patient with metastatic breast carcinoma.
Although hypercalcaemia is often encountered during the course of malignant disease, hypocalcaemia appears to be rather rare. We describe a 37-year-old patient with metastatic carcinoma of the breast, who developed extreme hypocalcaemia (as low as 0.75 mmol calcium per litre) after chemotherapy. This is caused by a combination of hungry-bone syndrome and an insufficient parathyroid response. Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ Case Reports
سال: 2015
ISSN: 1757-790X
DOI: 10.1136/bcr-2015-210003